Compound Detail
CHEMBL71752
VINPOCETINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL71752 |
| Name | VINPOCETINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | DDNCQMVWWZOMLN-IRLDBZIGSA-N |
| Therapeutic | ✓ Yes |
7
Targets
19
Activities
2
Assay Types
2
PK Parameters
20
Publications
14
Known Names
3
Indications
Molecular Properties
350.5
MW (Da)
4.15
ALogP
4
HBA
0
HBD
34.5
PSA (Ų)
0.78
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Attention Deficit Disorder with Hyperactivity Diabetic Nephropathies Epilepsy
ATC Classification
N06BX18
vinpocetine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
IC50 18 meas. best 7.41
Ki 1 meas. best 4.85
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 7.41 | 7.41 | 39.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.1 | 4.95 | 7943.3 | 6 |
| Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B CHEMBL4425 | IC50 | 5.1 | 5.1 | 7990.0 | 1 |
| Phosphodiesterase 1 CHEMBL2095150 | IC50 | 5.0 | 4.68 | 10000.0 | 3 |
| Phosphodiesterase 1 CHEMBL2095150 | Ki | 4.85 | 4.85 | 14000.0 | 1 |
| Phosphodiesterase 1 CHEMBL2097166 | IC50 | 4.72 | 4.72 | 19000.0 | 1 |
| Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A CHEMBL3421 | IC50 | 4.72 | 4.72 | 18840.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.52 | 4.52 | 30000.0 | 3 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Ka | 1.5 | 10'3/M/s | Homo sapiens |
| T1/2 | 13.1 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.5281/zenodo.13943903 | ADMET | 89 |
| - | 10.6019/CHEMBL5303304 | HEK-293T | 8 |
| - | 10.6019/CHEMBL5303304 | U2OS | 6 |
| 19734910 | 10.1038/nchembio.215 | Plasmodium falciparum | 6 |
| 31859156 | 10.1016/j.bmcl.2019.05.052 | Rattus norvegicus | 6 |
| - | 10.6019/CHEMBL5303304 | Fibroblast | 5 |
| 31859156 | 10.1016/j.bmcl.2019.05.052 | Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 5 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 4 |
| 22793155 | 10.1021/jm3007992 | No relevant target | 3 |
| 28406621 | 10.1021/acs.jmedchem.7b00302 | Liver | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 2 |
| 18183943 | 10.1021/jm070618k | Mus musculus | 2 |
| 18183943 | 10.1021/jm070618k | Rattus norvegicus | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
Data from ChEMBL 36 via Core Engine